BM
BMEZ.US BlackRock Health Sciences Trust II
17.18 USD
Close of Nov 14, 2026
12.95
17.85
- Market cap
- USD 1.07B
- P/E
- 5.1x
- P/B
- 1.00x
- ROE
- 3.1%
- Dividend yield
- 3.35%
- Fundamental score
- -
Ratios use the latest price and the fiscal year ending Dec 2024.
Is BMEZ.US undervalued?
Graham numberPrice17.18
Graham value36.14
Discount52.5%
BMEZ.US trades 52.5% below its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
BlackRock Health Sciences Trust II fundamental analysis
No fundamental analysis for BlackRock Health Sciences Trust II yet.
BlackRock Health Sciences Trust II stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
BlackRock Health Sciences Trust II financial statements
BlackRock Health Sciences Trust II annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Income Statement | ||||||
| Revenue | 114M | 5.24M | 59.7M | -26.0M | 8.19M | 24.1M |
| Gross Profit | - | 5.24M | 6.40M | -26.0M | 28.9M | 24.1M |
| Operating Income | - | 68.9K | 53.9K | 1.54M | 8.46M | 927K |
| EBITDA | 113M | 1.49B | 53.9K | -26.5M | 20.0M | 927K |
| Net Income | 113M | 79.6M | 59.1M | -26.5M | 20.0M | 23.5M |
| EPS | 1.00 | 0.71 | 0.52 | -2.10 | 1.44 | 1.77 |
| Balance Sheet | ||||||
| Total Assets | 1.73B | 555M | 649M | 606M | 596M | 775M |
| Total Liabilities | 93.5M | 8.62M | 23.0M | 5.93M | 7.97M | 6.03M |
| Shareholders' Equity | 1.64B | 3.02B | 626M | 600M | 588M | 769M |
| Cash & Short-term Investments | 501K | 212K | 960.00 | 3.12K | 534.00 | 26.6M |
| Total Debt | - | 103K | 212K | 679K | 60.7K | 278K |
| Cash Flow | ||||||
| Operating Cash Flow | -1.52B | 107M | -21.6M | -874K | 32.0M | 65.5M |
| Capital Expenditure | 0.00 | 0.00 | 4.00 | 0.00 | 0.00 | 0.00 |
| Free Cash Flow | -1.52B | 107M | -21.6M | -874K | 32.0M | 65.5M |
| Ratios | ||||||
| ROE | 6.9% | 2.6% | 9.4% | -4.4% | 3.4% | 3.1% |
| ROA | 6.5% | 14.3% | 9.1% | -4.4% | 3.4% | 3.0% |
| Net Profit Margin | 99.6% | 1,517.9% | 99.1% | - | 244.3% | 97.4% |
| Debt to Equity | - | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
BlackRock Health Sciences Trust II dividends
- Dividend yield
- 3.35%
- Forward dividend
- 1.32 USD
- Payout ratio
- 153.2%
- Ex-dividend date
- Dec 11, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2024 | USD 35.9M | 2.71 | 153.2% |
| 2023 | USD 35.1M | 2.52 | 175.3% |
| 2022 | USD 32.7M | 2.60 | - |
| 2021 | USD 29.0M | 0.26 | 49.1% |
| 2020 | USD 97.0M | 0.86 | 121.9% |
| 2019 | USD 33.3M | 0.30 | 29.4% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Who owns BlackRock Health Sciences Trust II
- Insiders 0.00%
- Institutions 28.04%
- Public & others 71.96%
- Shares outstanding 62.5M
BlackRock Health Sciences Trust II company profile
- Company name
- BlackRock Health Sciences Trust II
- Ticker
- BMEZ.US
- Exchange
- USA Stocks
- Listed since
- Jan 29, 2020
- Sector
- Financial Services
- Industry
- Health Care Providers & Services
- Fiscal year end
- December
- Address
- 50 Hudson Yards, New York, NY, United States, 10001
- Phone
- 212-810-5300
- Website
- -
BlackRock Health Sciences Trust II management
1- Dr. Xiang Liu Ph.D.Portfolio Manager